S. 467 · 110th Congress
FACT Act
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 110th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
DoddSponsor7 cosponsors · 5 D, 2 R
5 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
Fair Access to Clinical Trials Act of 2007 or the FACT Act - Amends the Public Health Service Act to require the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health (NIH), to establish and operate a data bank of information on clinical trials, to include: (1) a clinical trials registry of health-related…
What it does: CRS summary · Introduced in Senate · Jan 31, 2007
Fair Access to Clinical Trials Act of 2007 or the FACT Act - Amends the Public Health Service Act to require the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health (NIH), to establish and operate a data bank of information on clinical trials, to include: (1) a clinical trials registry of health-related interventions conducted to test the safety or effectiveness of any drug, biological product, or device intended to treat serious or life-threatening diseases and conditions; and (2) a clinical trial results database of health-related interventions to test the safety or effectiveness of any drug, biological product, or device.
Requires the Commissioner of Food and Drugs to make available to the public: (1) the full reviews conducted by the Food and Drug Administration (FDA) of new or supplemental new drug applications, including documentation of significant differences of opinion and the resolution of those differences; and (2) copies of written consultations on a drug's safety conducted by the Office of Surveillance and Epidemiology.
Requires the Secretary to assess civil monetary penalties for knowingly submitting inaccurate information to the FDA.
Allows the Secretary to correct any information included in the registry or database that is factually and substantively inaccurate, false, or misleading.
Extends requirements of this Act to clinical trials conducted outside of the United States under certain circumstances.
Prohibits a responsible person or a manufacturer from performing any act that prohibits, limits, or imposes unreasonable delays on the ability of an individual to discuss or publish the results of a clinical trial.
Requires the Secretary to enter into a contract with the Institute of Medicine to study the extent to which data submitted to the registry has impacted the public health.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: FACT Act
Also known as: Fair Access to Clinical Trials Act of 2007
Latest action (Jan 31, 2007): Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S1449-1454)
Policy area: Health · Origin: Senate · Introduced: Jan 31, 2007
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.